Plain-English translation of NCT03049462 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers are studying how , a medication that activates brown fat cells, affects your body's metabolism. Brown fat is a special type of fat that burns calories to produce heat. This study will measure changes in brown fat activity after taking the medication for four weeks, and will also look at how it affects insulin sensitivity and overall metabolic health.
Brown fat may help burn calories and improve metabolic health, but scientists don't yet fully understand how this medication affects brown fat in humans or whether activating brown fat could help with weight management and insulin resistance, especially in people with PCOS.
You likely qualify if…
You likely don't qualify if…
Depending on which study group you join, you will take either the medication or a placebo pill daily for four weeks. You will visit the research clinic multiple times for testing, including a special imaging scan (PET/CT) while exposed to cold to measure brown fat activity, and blood tests to check your metabolism and insulin sensitivity. The entire study takes several weeks to complete.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States